Background: Infection or stimulation of the innate immune system by nonspecific microbial antigens is thought to educate the immune system to respond appropriately to allergens, preventing allergy. Objective: To determine the immunologic pathways that might explain how infection/microbial exposure inhibits allergic sensitization. Methods: Immunologic studies of non-antigen-specific functions of CD8 memory cells, their maturation in vivo, and their effects in a mouse asthma model, to test the hypothesis that CD8 memory is shaped by innate immunity in a way that can inhibit allergic disease. Results: We found that CD8 memory T-cell (CD8 Tm) populations bridge innate and adaptive immunity by responding to either antigen or cytokines alone. CD8 Tm populations partially subvert the clonal selection process by activating their neighbors through induction of dendritic cell IL-12. Stimulation of innate or acquired immunity in the lung or gut causes expansion/maturation of CD8 Tm populations, which provide an early source of cytokines, enhance T H 1 immunity, and inhibit allergic sensitization and airway inflammation/ hyperresponsiveness in a non-antigen-specific fashion. Conclusion: CD8 T-cell-mediated immune memory is long-lived and can retain its capacity for rapid cytokine release in a nonantigen-specific fashion. This novel type of memory enhances T H 1 over T H 2 immunity and prevents allergic sensitization after exposure to environmental antigens or
Interaction between the innate and adaptive immune system is critical for establishing appropriate immune responses to newly encountered antigens and pathogens. In allergic disease, inappropriate immunity, skewed toward the T H 2 phenotype, results in immunopathology triggered by allergen exposure. Cells of the innate system provide an early source of IFN-g and other cytokines on first exposure to antigen, with IFN-g central for the T H 1 component of the response. 1 Atopic patients are deficient in IL-12 after allergen challenge, 2 and the immature phenotype of respiratory dendritic cells (DCs) contributes to poor IL-12 synthesis. 3 Thus, early IFN-g production is likely to be a limiting factor in ensuring a balanced response to inhaled antigens. Innate cells providing such DC-activating signals include NK cells, NKT cells, and gd T cells. It is becoming apparent that CD8 T cells, normally considered a part of adaptive immunity, also participate in innate immune responses.
It has been proposed that exposure to various microbes nonspecifically suppresses allergy, 4 increasing incidences of allergic diseases where infectious diseases are rare. Because early life events predict development of allergic disease, 5 nonspecific stimuli must have a long-lasting effect on adaptive responses to unrelated allergens. Memory lymphocytes with defined antigenic specificity emerge through the process of clonal selection. However, non-antigen-specific, innate immunity lacks immunologic memory because the receptors involved do not generate diverse specificities, and the cells are relatively short-lived. Therefore, epidemiologic evidence and data from rodent models suggest there must be nonantigen-specific or innate memory that develops in response to environmental antigens and pathogen-associated molecular patterns (PAMPs).
In the absence of Toll-like receptor (TLR) agonists, CD8 T cells may be essential for the T H 1 component of immunity, 6 and CD8 cells, triggered by cytokines alone, rapidly produce IFN-g. 7 Expression of nuclear factor of activated T cells c2 (NFATc2) in CD8 memory populations drives IFN-g and suppresses T H 2 and T H 17 responses in the lung. 8 The ability of respiratory syncytial virus infection to prevent airway inflammation in C57BL/6 mice is linked to CD8 IFN-g secretion. 9 Here we have investigated whether T H 1-promoting nonspecific responsiveness is provided by resting CD8 memory T-cell (CD8 Tm) populations, providing an immunologic pathway linking infection with prevention of allergic disease. 
METHODS Mice
C57BL/6 (B6) mice (6-8 weeks) were from Harlan UK (Oxford, United Kingdom [UK]). OT-1 and OT-2 T-cell receptor (TCR) transgenic mice (B6 background) were bred in our facility. CD8
1 OT-1 and CD4 1 OT-2 T cells recognize ovalbumin peptides SIINFEKL (SII) and ISQAVHAAHAEINEAGR (ISQ), respectively. Protocols complied with UK Home Office regulations and were approved by our Animal Welfare Committee.
Cell isolations and T-cell:DC assays
For antibodies/reagents, see this article's Online Repository at www.jacionline.org. Serum IgE was measured by ELISA 10 and IL-12 p70 by ELISA kit (R&D Systems, Abingdon, UK). DCs were purified from spleens, CD8 naive/memory T cells from lymph node/spleen, and lymphocytes from liver and lung (see this article's supplementary Methods text in the Online Repository). Proliferation was measured by 3 H-thymidine or carboxyfluorescein diacetate succinimidyl ester (CFSE) labeling, and T-cell:DC cocultures were as detailed in this article's supplementary Methods text in the Online Repository.
Eimeria vermiformis infection experiments
B6 mice were infected 28 days after birth with 10 to 1000 Eimeria vermiformis sporulated oocysts in sterile water by oral gavage. Three and 17 days later, some groups were allergen-sensitized with 10 mg ovalbumin absorbed to 1.8 mg alum intraperitoneally, and 29 days later challenged with 1 dose of 100 mg ovalbumin in PBS intranasally. Splenocytes were analyzed for CD8 Tm activity on day 31. In some experiments, ovalbumin sensitization was not started until day 24 postinfection, and mice were killed on day 52. There was no change in spleen cellularity or proportions of CD8 cells in infected animals.
CD8 T-cell depletion and adoptive transfer
Mice were depleted of CD8 T cells (>99%) as detailed in this article's supplementary Methods text in the Online Repository. For transfer of CD8 memory, mice were injected intravenously with 5 3 10 6 OT-1 CD8 cells, or PBS alone, and immunized on the same day with 50 mg SII peptide 1 25 mg anti-CD40 subcutaneously. SII-specific CD8 cells were identified with H-2K b -SII pentamer/CD8 staining.
T-cell-dependent peptide-induced airway inflammation model B6 mice were adoptively transferred with 5 3 10 6 OT-2 CD4 cells intravenously, sensitized with 10 mg ISQ/2 mg alum intraperitoneally on day 0, and challenged daily with 5 mg ISQ in 50 mL PBS intranasally on days 10 to 14. On day 15, lung resistance and compliance (resistance-lung and compliancedynamic) were measured as described. 11 Data are expressed as percentage of baseline measurements. Bronchoalveolar lavage (BAL) inflammatory cells were counted by flow cytometry essentially as described, 12 with addition of fluorescein isothiocyanate-Gr-1 antibody to identify neutrophils positively. BAL cells were also stained for T1/ST2/CD3/CD4 to enumerate T H 2 CD4 cells.
Statistics and data analysis
Nonparametric (Mann-Whitney) tests were used to compare results from groups of mice. Values of P < .05, P < .01, and P < .005 were considered significant and are indicated in Figs 1 through 5. Flow cytometry results are shown with mean percent staining 6 SEM from 3 independent experiments.
RESULTS
Cytokine-stimulated CD8 Tms release early IFN-g and develop into innate effectors CD8 memory cells produced IFN-g immediately after stimulation through the TCR or by stimulation with cytokines alone (see this article's Fig E1 in the Online Repository at www.jacionline.org). Only CD44 hi memory T cells produced early IFN-g, and these were present in both lymphoid and nonlymphoid tissues such as lung and liver (Fig E1, A) . In the absence of TCR ligation, a combination of IL-12 and IL-18, and to a lesser extent IL-12 1 IL-15, induced rapid IFN-g (Fig E1, B) , and this cytokineinduced IFN-g was similar in both central and effector memory CD8 cells (Fig E1, C) . IFN-g secretion kinetics were dramatically delayed in naive (CD44 lo ) compared with memory (CD44 hi ) fractions with either stimulus (Fig E1, D) . Counterstaining for DX5, NKG2A/C/E, and ab/gd TCR suggested all CD8 IFN-g 1 cells were conventional ab T cells and not NKT cells (not shown).
Proliferation assays of purified naive and memory CD8 cells (Fig 1, A) showed that IL-12 and IL-18 acted synergistically, mainly on memory cells, to induce proliferation. Progeny of IL-12/IL-18-induced cell division retained the capacity for early IFN-g production (Fig 1, B) , because restimulation of CFSElabeled cells after 3 days with cytokines induced very high levels of IFN-g in divided but not unresponsive cells. Proliferating cells also expressed CD25 after 3 to 4 cell divisions (Fig 1, C) , indicating full activation and effector development. This was confirmed by kinetic analysis of IFN-g production (Fig 1, D; n 5 3). Freshly isolated CD8 Tms, when stimulated with IL-12 1 IL-18, produced IFN-g at low frequency, with similar levels detected after 5 or 15 hours. After 3 days of priming in IL-12/IL-18, however, restimulated CD8 Tms were nearly all high-level IFN-g 1 by 5 hours, but staining had declined by 15 hours. Thus, IL-12/IL-18 induced blastlike cells that released IFN-g with the kinetics and quantities characteristic of T effectors. TNF-a, but not IL-4 or IL-10, was detectable from CD8 Tms, but only after prolonged (24-hour) stimulation with both IL-12 and IL-18 (not shown). Priming/restimulation with IL-12 1 IL-18 also induced expression of CD40 ligand, another critical IL-12-inducing signal, albeit at lower levels than in conventional TCR-induced effectors (Fig 1, E) . Furthermore, perforin expression, indicative of cytotoxic function, was induced in CD8 Tms after IL-12/IL-18 culture (see this article's Fig E2 in the Online Repository at www.jacionline.org).
CD8 Tms stimulate DC IL-12 and respond to TLR agonist-activated DCs
Because CD8 Tms were a major source of early IFN-g, we hypothesized that collaboration between CD8 Tms, DCs, and inflammatory signals is critical for initiating DC IL-12 production. Purified CD8 Tms from OT-1 mice were stimulated with splenic DCs and SIINFEKL (SII) peptide, an irrelevant peptide (RGY-VYQGL), or whole ovalbumin 6 cytosine-phosphate-guanosine (CpG) DNATLR-9 agonist (Fig 2, A; n 5 3). Memory CD8 T lymphocytes stimulated secretion of IL-12 p70 from DCs, but very low levels were detected in naive CD8 cell cocultures. This was dependent on cognate interaction because only the antigenic peptide induced IL-12. Low-level IL-12 could also be elicited by cross-presented whole ovalbumin; this was enhanced by CpG. Neutralizing antibodies were then used to determine mechanisms of IL-12 induction (Fig 2, B ; n 5 4). Anti-IFN-g consistently blocked IL-12 secretion induced by CD8 Tms; anti-CD40L had no significant effect. Mice were then depleted of CD8 T cells by using anti-CD8ß antibody (see Fig E3 in the Online Repository at www.jacionline.org) and injected 24 hours later with staphylococcal enterotoxin B (SEB) superantigen, which induces circulating IL-12 within 4 hours. Depletion of CD8 T cells significantly reduced the release of early IL-12 (Fig 2, C ; n 5 7), confirming a role for CD8 Tms in innate immunity.
We asked whether activation of DCs induced corresponding activation of CD8 Tms in a noncognate, antigen-independent fashion. CD8 T lymphocytes stimulated with TLR agonists, without antigen, failed to proliferate. However, if DCs were added, high levels of proliferation were induced by TLR-9 agonist CpG and TLR-1/2 agonist Pam 3 CysK4, but not TLR-3 agonist poly I:C (Fig 2, D; n 5 3), with highest proliferation in the memory fraction. To test whether TLR agonists alone prime CD8 Tms in vivo, we challenged mice intranasally with CpG alone (Fig 2, E ; n 5 3). This primed CD8 Tms for heightened rapid IFN-g production, most dramatically in lung T cells but also in draining lymph nodes. Bidirectional activation signals can therefore occur between CD8 Tms and DCs during innate/early immune responses.
Infection enhances the responsiveness of CD8 Tms
We predicted that microbial exposure, resulting in DC activation, would prime a non-antigen-specific response in CD8 cells, amplifying IL-12 secretion. To test this using a live infection, we used Eimeria, an intracellular protozoan parasite that infects intestinal epithelia, causes coccidiosis, and is commonly contracted in early life. Infection of mice with E vermiformis significantly enhanced early IFN-g in splenic CD8 Tms when assessed by using IL-12/IL-18 stimulation (Fig 3, A; n 5 16). This effect was apparent at 31 and 52 days after infection, although parasites are cleared in these animals by day 16 (not shown). This suggested a lasting effect of infection on CD8 memory. Mean IFN-g triggered by anti-CD3/CD28 appeared higher in infected mice, but this did not reach statistical significance in all groups. Although most mice were also immunized with ovalbumin, ovalbumin treatment had no significant effect on CD8 IFN-g production. The degree of CD8 IFN-g enhancement was dependent on the challenge dose of Eimeria oocysts (Fig 3, B ; n 5 8). Cells stimulated with Eimeria extract failed to stain positive for IFN-g (not shown), suggesting the enhanced response was not a result of restimulation of Eimeria antigen-specific CD8 Tms.
TCR triggering activates T-cell:T-cell activation via DCs
Because CD8 Tms elicited cytokines from DCs and DC-cytokines stimulate CD8 Tms, we postulated that TCRdriven CD8 Tms would activate bystander, non-antigen-specific CD8 Tm. TCR transgenic cells were stimulated with peptide 1 DCs and labeled, nontransgenic bystander cells (Fig 4, A; n 5 3) . Nontransgenic cells produced no IFN-g when stimulated with peptide 1 DC alone (not shown). However, antigen-triggered OT-1 CD8 Tm activated neighboring nonspecific CD8 Tm to produce IFN-g. Addition of anti-IL-12/anti-IL-18 partially inhibited the bystander response, which was greater than that induced by IL-12/IL-18 alone, suggesting other DC-cytokines are involved. To demonstrate such bystander activation in vivo, we transferred nonspecific CFSE-labeled CD8 cells into B6 or OT-1 animals (Fig 4, B; n 5 3) and challenged with SII. Cell division was observed in B6 CD8 cells when resident in an OT-1 mouse, but only if surrounding T cells were activated with SII. The same cells transferred to a nontransgenic mouse immunized with peptide failed to proliferate, demonstrating that B6 cell division was dependent on OT-1 T-cell activation and not the appearance of antigen-specific cells or presence of contaminating endotoxin in the antigen preparation. Furthermore, analysis of Va2 and Vb5 TCR elements, which are associated with ovalbumin-specific responses (Fig 4, B , lower panels), showed that bystander-activated cells were not enriched in either Va2 1 or Vb5 1 populations. Therefore, the response was not antigen-specific.
Antigen-specific CD8 responses leave an imprint on non-antigen-specific CD8 Tm populations
The predicted consequence of bystander activation was that non-antigen-specific memory would accompany the development of antigen-specific CD8 memory, providing a conduit for regulation of unrelated immune responses. To test this, we hi /CD44 lo CD8 T lymphocytes were stimulated 6 DC/TLR agonists. Mean proliferation 6 SD of triplicates is shown; 1 of 3 similar experiments. E, CpG treatment expands and primes lung CD8 Tms. Lung or mediastinal lymph node cells from mice treated 3 and 6 days previously with 10 mg CpG intranasally (right) or PBS (left) were CD44-labeled and stimulated with anti-CD3/CD28 or IL-12/IL-18. IFN-g staining in gated CD8 T lymphocytes is shown (n 5 3). in, Intranasal; LN, lymph node.
induced strong in vivo CD8 responses entirely directed to SII peptide (Fig 4, C; n 5 4) . This allowed us to identify all antigenspecific CD8 T lymphocytes using MHC pentamer staining. OT-1 CD8 T lymphocytes, which all stain positive with MHC pentamer (not shown), were transferred to B6 recipients given SII in anti-CD40 adjuvant, resulting in strong expansion of SIIspecific CD8 T lymphocytes. Control mice given peptide/anti-CD40 vaccine without OT-1 cells failed to respond. After the antigen-specific response had declined, we analyzed each group for early IFN-g production in non-antigen-specific CD8 T lymphocytes (MHC pentamer-negative), using strict gating. Activation of nonspecific CD8 Tms was significantly enhanced in mice that had previously had a strong ovalbumin-specific response compared with controls. This effect was most dramatic in lymph nodes but was also apparent in spleen. Thus, antigenspecific CD8 responses result in a lasting imprint of enhanced maturity on nonspecific populations.
Non-antigen-specific CD8 Tms suppress allergic airway responses and IgE secretion induced by a neoantigen
Finally, we asked whether nonspecific CD8 Tms inhibit allergic airway disease by using 2 distinct approaches. First, we used anti-CD8b depletion (as in Fig 2, D) . To confirm that CD8 memory was the critical factor, we also induced defined SII-specific CD8 memory pools in B6 recipients using OT-1 cells and peptide vaccine as in Fig 4, C. Because allergen-specific CD8 T lymphocytes are known to suppress allergic responses, we designed a model in which airway inflammation was entirely dependent on CD4 cells directed to a single class II-restricted peptide (ISQ). This excluded antigen-specific effects because there was no cross-reactivity between responses to the 2 peptides (not shown). OT-2 CD4 cells were transferred into B6 mice (predepleted of CD8 T lymphocytes or given control IgG 24 hours previously), sensitized with ISQ peptide/alum, and repeatedly challenged intranasally with ISQ. CD8b depletion greatly enhanced IgE levels (Fig 5, A; n 5 6) . Challenge of control mice recruited T cells into the airways, but few eosinophils or neutrophils (Fig 5, B) . CD8b depletion increased eosinophil numbers with no significant change in neutrophils or T cells. Data from BAL CD4
1 T H 2 analysis using the T1/ST2 T H 2 marker (Fig 5,  C) were not quite significant. Finally, anaesthetized mice were challenged with methacholine aerosols and bronchoconstriction was assessed (Fig 5, D) , demonstrating significantly enhanced airway responsiveness in CD8b-depleted mice.
To determine effects of transferred memory, mice were given either OT-1 CD8 T lymphocytes 1 SII vaccine or vaccine alone as in Fig 4, C, and sensitized with ISQ in Fig 5, A-C, 2 weeks later (Fig 5, E-H ; n 5 6). Only mice receiving OT-1 CD8 T lymphocytes developed significant SII-specific CD8 Tms (Fig 5, E) . IgE data are omitted because injection of anti-CD40, even in naive mice, causes a large increase in IgE levels. After rechallenge, eosinophilia and T-cell infiltration of airways were observed, with few neutrophils (Fig 5, F) . Eosinophilia, T1/ST2
1 T H 2 infiltration (Fig 5, G) , and airway reactivity (Fig 5, H) were all significantly suppressed by transfer of the OT-1 population, implying that CD8 memory would regulate allergic asthma in a nonspecific fashion. hi populations shown (n 5 16). B, As in A, but different doses of E vermiformis oocysts were used; IFN-g from day 31 CD8 T lymphocytes stimulated with IL-12 1 IL-18 is shown (n 5 8). *P < .05; **P < .01; ***P < .005. 5 3) . B, CFSE-labeled nonspecific CD8 T lymphocytes were injected intravenously into OT-1 mice immunized with PBS/SII or into B6 mice given peptide as control. Bystander CD8 division (CFSE dilution) in lymph nodes after 3 days is shown (upper panels; n 5 3). Va2/Vb5 TCR staining in bystanderactivated group is shown in lower panels. C, An antigen-specific CD8 response leaves an imprint on non-antigen-specific CD8 Tms. B6 mice given PBS or OT-1 cells were immunized with SII 1 anti-CD40 (vaccine) as indicated. Left panel, Percent SII-specific CD8 in blood. Right panel, IFN-g staining in gated non-antigen-specific (Pentamer -) CD8 T lymphocytes (n 5 4). *P < .05; ***P < .005. ip, Intraperitoneal; iv, intravenous; LN, lymph node; SC, subcutaneous; Tm, memory T lymphocyte.
Our results are consistent with the theory that mature CD8 memory increases the availability of IL-12 from DCs early in responses to neoantigens, resulting in inhibition of T H 2 development via immune deviation. How this might explain the role of microbial exposure in allergy is illustrated in Fig 6. 
DISCUSSION
A central dogma of immunology has been that T-cell responses are controlled by 2 signals: signal 1 (TCR/antigen) and signal 2/3 (costimulatory molecules/cytokines) induced by danger signals and PAMPs. It has been assumed that only signal 1 results in immunologic memory, whereas signals 2 and 3 determine the nature and longevity of the response. In this study, we asked whether it is possible that signals 2/3 also result in a form of immunologic memory, not for specific antigen, but for the amount of environmental danger experienced or the intensity of previous immune responses. If true, this would explain a key proposal of the hygiene hypothesis: that dangerous environments strengthen the immune system in a non-antigen-specific fashion, leading to potent T H 1 immunity and little allergy.
CD8 Tms possess unique characteristics that allow them to bridge innate and adaptive immunity. They are activated by cytokines alone in the absence of TCR triggering. They proliferate and secrete cytokines IFN-g and TNF-a in response to IL12 1 IL-18 7, 13 (see Fig E1) , or IL-12 1 IL-15. CD8 Tms are longlived because of self-replication in response to IL-15 14 and migrate to peripheral tissues. Non-antigen-specific division of CD8 Tms is enhanced by IL-12. 15 Our data indicate these cells participate in early activation of tissue DCs, enhancing IL-12 secretion. Although NK/NKT cells and gd T cells can also perform this function, they are innate cells that do not mediate long-lived memory. Here we showed that CD8 T cells were partially required for early IL-12 release after SEB injection. It is likely that NKT cells may have provided another stimulus in this system because they can express Vb7/8, which bind SEB.
16 CD8 Tms are a major source of early IFN-g after LPS challenge. 17 By contrast, CD4 Tcell stimulation with TLR ligands may enhance survival but does 1 CD4 1 T H 2 cells. D, Airway reactivity to methacholine; all n 5 6. E-H, Mice were injected with PBS, SII/anti-CD40 vaccine, and OT-1 CD8 T lymphocytes as in Fig 4, C. E, Day 14 ovalbumin-specific CD8 T lymphocytes in blood. Mice were sensitized and challenged with ISQ/OT-2 cells as in A, starting 7 days after CD8 transfer. BAL cell counts (F), T H 2 cells (G), and airway reactivity (H) are shown after 15 days (n 5 6). *P < .05; **P < .01.
J ALLERGY CLIN IMMUNOL VOLUME 122, NUMBER 5 not induce proliferation. 18 Like CD8 Tms, established T H 1 effector cells respond to IL-12 1 IL-18 by producing IFN-g. 19 However, T H 1 effectors generate poor memory in experimental models, perhaps because CD4 Tms do not respond to IL-15. 20 Bystander effects of CD4 cells are therefore likely to be short-lived in comparison with CD8 T lymphocytes.
The existence of early-activated CD8 T lymphocytes was first demonstrated when CD8 cells from rats immunized with antigen with no adjuvant were found to express a lectin-binding activation marker within 24 hours. 21 The responder frequency of 50% indicated an innate type of response, and depletion of early-activated cells with ricin resulted in potent IgE responses. Although ricin in castor bean dust clearly acts similarly in human beings, 22 we have found that such a response cannot be induced in pathogen-free animals, suggesting that infection sensitizes CD8 populations. A similar effect may cause differences between immune responsiveness of human beings raised in hygienic or pathogen-rich environments. This might also explain the severe inflammatory reactions to superagonistic CD28 antibody seen in human beings but not laboratory animals. 23 Our concept of innate, or nonspecific, memory is clearly supported by the observation that CD8 Tms expanded by cytokines alone release IFN-g with the kinetics and quantity of effector T cells. This priming effect is a key feature of antigenspecific effector activities. Expression of CD40L on cytokinerestimulated effectors would provide another IL-12-inducing signal to DCs. Chronic exposure to PAMPs may amplify maturation of CD8 Tms through this priming/restimulation mechanism, resulting in robust innate memory and propensity for T H 1 responses. Our in vitro IL-12 induction model confirmed the importance of rapid IFN-g secretion for synthesis of IL-12 by DCs. For the first time, we showed that CD8 Tms, triggered via their TCR, activate bystander, non-antigen-specific CD8 Tms to amplify the early response, and this can occur in vivo, resulting in expansion of bystander cells. This pathway defies the principles of clonal selection, because T cells are activating each other, via DCs, without presenting antigen to each other. The idea that specific immunity could leave a weaker imprint on nonspecific bystander populations was confirmed by inducing a defined peptide-specific CD8 response and then demonstrating the imprint (enhanced rapid IFN-g) in CD8 Tms, which we could confirm were not antigen-induced and were present several weeks after the initial response (Fig 4, C) . Therefore, viral infection in early life could increase CD8 Tm maturity globally. This would increase the likelihood of T H 1 immunity to a neoantigen.
The ability of nonspecific CD8 Tms to inhibit eosinophilic airway inflammation, lung T H 2 responses, and airway hyperreactivity is consistent with other studies. CD8 T lymphocytes transferred directly into the airways suppressed allergic airway inflammation, 24 and IL-15 transgenic mice, which have enhanced CD8 memory, are resistant to airway hyperreactivity. 25 We found nonspecific CD8 T lymphocytes also inhibit IgE production. Because CD8 Tms can reside for long periods in the lung, 26 they are in an ideal position to influence the earliest events in T-cell priming to inhaled allergens. CD8 Tms expanded in IL-12/IL-18 retain their TCRs (not shown), which would allow them to respond rapidly to neoantigens via TCR cross-reactivity. Antigen-specific CD8 responses to inhaled allergen are rapid and suppress eosinophilia. 27 A combination of antigen-specific and nonspecific CD8 Tms, therefore, is probably involved in prevention of asthma.
The nature of gut flora may have a dominant role in shaping nonspecific memory because of the large bacterial load present at the gastrointestinal mucosa. Helminth infections are known to suppress allergy despite stimulating T H 2 immunity. 28 As we show here, Eimeria infection, which induces CD4 T H 1-associated immunity, primes CD8 Tms for enhanced responsiveness. Recent data also indicate that Eimeria infection suppresses allergic airway inflammation after allergen challenge (D. Gibbons, S. Haque, A. Smith, and A. Hayday, unpublished data, September 2008). We therefore propose that increased maturity of CD8 Tms built up through extended antigenic experience reflects an innate memory of the levels of danger/infectious burden encountered. Development of this memory primes for rapid elimination of pathogens but also educates the immune system to respond appropriately to allergens to avoid allergic disease.
METHODS

Antibodies and reagents
For in vivo experiments, azide-free anti-CD8b antibody (53-5.8; BD Biosciences, Oxford, United Kingdom [UK]), control rat IgG (Sigma, Poole, UK) or anti-CD40 (3/23; Serotec, Oxford, UK) were used. Anti-CCR3-phycoerythrin and anti-IL-12 were from R&D Systems (Abingdon, UK); anti-IL-18 was from MBL Ltd (Watertown, Mass). Biotin or phycoerythrin-labeled anti-CD44 (IM7.8.1), anti-CD25 (PC61), and Gr-1-fluorescein isothiocyanate were from Caltag-MedSystems (Towcester, UK) and antiperforin-phycoerythrin (eBioOMAK-D) from Insight Biotec (Wembley, UK). Neutralizing azide/endotoxin-free anti-IFN-g (R4-6A2), anti-CD40L (MR1), and control antibody were from BD Biosciences. mouse plasmacytoid dendritic cell antigen 1 (mPDCA1) antibody, specific for plasmacytoid DC, was from Miltenyi Biotec (Bisley, UK). The T1/ST2 (DJ8) T H 2-specific antibody was from MD Biosciences (Zurich, Switzerland). All other antibodies were from BD Biosciences. StreptavidinQdot-800 (Cambridge Bioscience UK, Cambridge, UK) was used to reveal biotin antibody staining. PE-H-2K b /SIINFEKL Pro5 Pentamer (ProImmune Ltd, Oxford, UK) staining was used to identify MHC class I-restricted ovalbumin-specific CD8 cells. CpG 1826 DNA (TLR-9 agonist) was from VHBio (Gateshead, UK), and palmitoyl-cysteinyl-seryl-lysyl-lysine lipopeptide (Pam 3 CSK4, TLR1/2 agonist) was from EMC Microcollections (Tubingen, Germany). SII, ISQ, and control vesicular stomatitis virus peptide RGYVYQGL (RGY) were synthesized by Perbio Mimotopes (Tattenhall, UK). Other reagents were purchased from Sigma.
Cell separations and flow cytometry
Dendritic cells were purified from B6 splenocytes by labeling with antiCD11c-biotin (0.5 mg/10 6 cells) followed by antibiotin microbeads (Miltenyi Biotec). CD11c 1 cells were selected by 2 rounds of magnetic selection (auto-MACS; Miltenyi Biotec) and were >80% CD11c 1 MHC class II hi CD14
-. CD4/ CD8 T cells (>98% purity) were isolated from spleen/lymph node by using anti-CD4/CD8 microbeads. High purity, allophycocyanin (APC)-depleted CD8s and CD44 hi /CD44 lo CD8 separations were performed by negative selection and further magnetic separation after labeling with 0.05 mg anti-CD44-biotin per 10 8 cells. Cell fractionations and staining were performed in PBS 1 1% FCS. Cell cultures were in Dulbecco modified Eagle medium (Invitrogen, Paisley, UK) 1 10% FCS (Sera-Lab, Loughborough, UK) 1 L-glutamine (2 mmol/ L), nonessential amino acids (1 mmol/L each), gentamicin (50 mg/mL), and 2-mercaptoethanol (50 mmol/L). Recombinant IL-12 (Peprotech, London, UK) and IL-18 (R&D Systems) were added at 10 ng/mL. Anti-CD3 (145-2C11) was used to coat 24-well plates (1 mg/mL in PBS, 48C overnight), whereas anti-CD28 (37.51) was added to cultures at 1 mg/mL. Cytokine profiles were determined by restimulation of washed cells in the presence of 3 mmol/L monensin followed by intracellular cytokine staining as described. 10 Flowcytometric analysis was using a FACScalibur (BD Biosciences), with gating on live cells determined by forward versus side scatter. IFN-g secretion was measured in supernatants of cultured CD8 naive or memory cells (2 3 10 6 / mL) collected at sequential time points and measured by ELISA using antibody pairs (BD Biosciences according to the manufacturer's protocol).
T-cell proliferation
In vitro proliferation was measured in triplicate cultures of 0.2 mL CD8 cells (2.5 3 10 6 /mL) in 96-well plates. After 72 hours of culture, 0.5 mCi 3 H-thymidine (Amersham Ltd, Amersham, UK) was added to each well overnight, cells were harvested onto glass fiber filters, and scintillation counting was performed with the Topcount system (Perkin Elmer, Beaconsfield, UK). For tracking cell division by CFSE dilution, cells were washed twice in PBS, labeled with 2.5 mmol/L CFSE (Invitrogen) for 10 minutes at 378C, washed, and cultured for 3 days before flow cytometry. For the in vivo proliferation experiment, B6 CD8 cells were labeled with CFSE as described and resuspended in PBS for intravenous transfer into tail veins of B6 or OT-1 recipient mice (5 3 10 6 cells in 100 mL). Mice then received 25 mg SII peptide in PBS or PBS alone intraperitoneally. Three days later, axillary, inguinal, and cervical lymph nodes were stained for CD44, Va2, and Vb5 and analyzed by flow cytometry.
T-cell:DC cocultures
For IL-12 induction, CD8 populations as described from OT-1 mice were cultured in U-shaped microtiter wells at 10 6 /mL with addition of DCs at 5 3 10 5 /mL, peptides at 2 mg/mL, ovalbumin at 500 mg/mL, CpG at 1 mg/mL, and antibodies at 10 mg/mL. Supernatants were collected after 24 hours for IL-12 measurements. For proliferation assays, CD8 fractions from B6 mice were cultured at 2.5 3 10 6 /mL 6 DCs at 2.5 3 10 5 /mL, with CpG, Pam 3 CSK4, or poly I:C at 1 mg/mL. For bystander activation experiments, CFSE-labeled B6 CD44
hi CD8s, OT-1 CD44 hi CD8s, and DCs were prepared and cocultured at 2 3 10 6 /mL, 1 3 10 7 /mL, and 1 3 10 6 /mL, respectively. SII peptide (2 mg/ mL) and antibodies to IL-12 and IL-18 (both 10 mg/mL) were added as indicated. After 15 hours, 3 mmol/L monensin was added, and intracellular staining was performed after a further 4 hours.
Analysis of lung and liver infiltrates
For intrahepatic lymphocyte isolation, livers were perfused with 5 mL cold PBS/FCS via the hepatic portal vein in situ, then dissociated by using a nylon mesh and washed before digestion in RPMI-1640 1 10% FCS 1 0.7 mg/mL collagenase type IV for 1 hour at 378C. Cells were released by pipetting and washed in PBS/FCS. Cells were then suspended in 24% metrizamide in PBS and overlaid with culture medium before density gradient centrifugation at 1500g. Lymphocytes were harvested from the interface. For lung cell isolation, lungs were cut into fragments, digested as described, and used without density gradient purification.
CD8 T-cell depletion and adoptive transfer
Mice were depleted of CD8 T cells by injection of 75 mg anti-CD8b antibody intraperitoneally, or rat IgG control. Depletion was confirmed by flow-cytometric analysis of peripheral blood 24 hours later by using CD8a, CD3, CD11c, and mPDCA1 markers. This showed that there was >99% depletion of CD8 T cells with no effect on myeloid or plasmacytoid DC numbers (Fig E3) . Effective CD8 T-cell depletion was also observed in lymph node, spleen, and lung cells and lasted for >3 weeks (not shown). 
